Skip to main content
Professional Technical IVT

programmed death-1

Also written as: PD-1 — programmed death-1

An immune checkpoint receptor on T cells that inhibits immune responses when activated.

Full Definition

Programmed death-1 (PD-1) is a cell surface receptor found on activated T cells, B cells, and natural killer cells that serves as an immune checkpoint protein. When PD-1 binds to its ligands (PD-L1 or PD-L2), it sends an inhibitory signal that suppresses T-cell activation and proliferation, effectively putting the brakes on immune responses. In cancer, tumor cells often exploit this pathway to evade immune detection. PD-1 inhibitors, such as pembrolizumab and nivolumab, block this interaction to enhance anti-tumor immunity and have revolutionized cancer treatment across multiple tumor types.

Usage

Usage note: Spell out on first use, then use PD-1. Note the hyphen in both full form and abbreviation.

In Context

  • "The patient showed excellent response to PD-1 blockade therapy." — Clinical progress note
  • "Programmed death-1 expression was evaluated by immunohistochemistry." — Laboratory report

Also known as

PD-1

Don't confuse with

PD-L1 CTLA-4

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON